MiT family translocation renal cell carcinoma

Pedram Argani1

  • 1Department of Pathology, The Johns Hopkins University School of Medicine, The Johns Hopkins Hospital, 401 North Broadway, Weinberg 2242, Baltimore, Maryland 21231.

Summary

MiT family translocation renal cell carcinomas (RCCs), involving TFE3 or TFEB gene fusions, share clinical, morphologic, and immunohistochemical similarities. These rare kidney cancers are now grouped together, aiding diagnosis and understanding.